Effects of oral magnesium and vitamin d co-supplementation on glycemic control in type 2 diabetes mellitus: a double-blinded, randomized, control trial

Phase 1

• Conditions: Type 2 diabetes mellitus with hemoglobinA1C 7.5-9%; Type 2 Diabetes Mellitus; Noninsulin-Dependent Diabetes Mellitus; Diabetes Mellitus, Noninsulin-Dependent; Diabetes, Type 2; Diabetes Mellitus, Adult-Onset

• Registration Number: TCTR20230707008
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-07
• Study Completion: 2024-08-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

> 18 years of age of Type 2 diabetes mellitus with hemoglobin A1C 7.5-9%

Exclusion Criteria

Currently use of oral magnesium or vitamin D
Diuretics use within 4 weeks
Pregnancy
Chronic kidney disease (eGFR<45)
Chronic diarrhea
Active cardiac condition
Active malignancy
Hypercalcemia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HemoglobinA1C 12 weeks Mean difference

Secondary Outcome Measures

Name	Time	Method
HOMA-IR 12 weeks Mean difference,FBS 12 weeks Mean difference,Vitamin D level 12 weeks Mean difference,Serum magnesium level 12 weeks Mean difference